Medications for Paroxysmal Extreme Pain Disorder

9 results
Sun Pharmaceutical Industries, Inc.
Usage: Bromfenac ophthalmic solution 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients following cataract surgery.
Amneal Pharmaceuticals NY LLC
Usage: Bromfenac ophthalmic solution, 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.
Lupin Pharmaceuticals Inc
Usage: Bromfenac ophthalmic solution, 0.075%, is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.
Dr. Reddy's Laboratories Inc.
Usage: Bromfenac Ophthalmic Solution 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.
Bausch & Lomb Americas Inc.
Usage: Bromfenac Ophthalmic Solution 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.
Sun Pharmaceutical Industries, Inc.
Usage: BromSite (bromfenac ophthalmic solution) 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients following cataract surgery.
Pacific Pharma, Inc.
Usage: Ketorolac tromethamine ophthalmic solution is indicated for reducing ocular pain and burning/stinging after corneal refractive surgery.
Bausch & Lomb Americas Inc.
Usage: Loteprednol Etabonate Ophthalmic Gel is a corticosteroid used to treat post-operative inflammation and pain following ocular surgery.

Prolensa (bromfenac sodium)

(Bromfenac Sodium)
Bausch & Lomb Incorporated
Usage: PROLENSA® is indicated for treating postoperative inflammation and reducing ocular pain in patients who have undergone cataract surgery.